Brand names: RISEDRONATE SODIUM
12.1 Mechanism of Action Risedronate has an affinity for hydroxyapatite crystals in bone and acts as an antiresorptive agent. At the cellular level, risedronate inhibits osteoclasts. The osteoclasts adhere normally to the bone surface, but show evidence of reduced active resorption (for example, lack of ruffled border). Histomorphometry in rats, dogs, and minipigs showed that risedronate treatment reduces bone turnover (activation frequency, that is, the rate at which bone remodeling sites are activated) and bone resorption at remodeling sites.
Contraindications
10 documented side effects by frequency
No community discussions found for RISEDRONATE SODIUM yet.
Every figure on this page links back to its primary source. See data sources for full provenance.
3 available comparisons
Dosage Forms
Tablet
Route
Oral